Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.

<h4>Introduction</h4>Physiologically relevant pre-clinical ex vivo models recapitulating CNS tumor micro-environmental complexity will aid development of biologically-targeted agents. We present comprehensive characterization of tumor aggregates generated using the 3D Rotary Cell Culture...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stuart J Smith, Martin Wilson, Jennifer H Ward, Cheryl V Rahman, Andrew C Peet, Donald C Macarthur, Felicity R A J Rose, Richard G Grundy, Ruman Rahman
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0b5326e51f734aaabbbf930afbebf33f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0b5326e51f734aaabbbf930afbebf33f
record_format dspace
spelling oai:doaj.org-article:0b5326e51f734aaabbbf930afbebf33f2021-11-18T08:04:37ZRecapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.1932-620310.1371/journal.pone.0052335https://doaj.org/article/0b5326e51f734aaabbbf930afbebf33f2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23272238/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Introduction</h4>Physiologically relevant pre-clinical ex vivo models recapitulating CNS tumor micro-environmental complexity will aid development of biologically-targeted agents. We present comprehensive characterization of tumor aggregates generated using the 3D Rotary Cell Culture System (RCCS).<h4>Methods</h4>CNS cancer cell lines were grown in conventional 2D cultures and the RCCS and comparison with a cohort of 53 pediatric high grade gliomas conducted by genome wide gene expression and microRNA arrays, coupled with immunohistochemistry, ex vivo magnetic resonance spectroscopy and drug sensitivity evaluation using the histone deacetylase inhibitor, Vorinostat.<h4>Results</h4>Macroscopic RCCS aggregates recapitulated the heterogeneous morphology of brain tumors with a distinct proliferating rim, necrotic core and oxygen tension gradient. Gene expression and microRNA analyses revealed significant differences with 3D expression intermediate to 2D cultures and primary brain tumors. Metabolic profiling revealed differential profiles, with an increase in tumor specific metabolites in 3D. To evaluate the potential of the RCCS as a drug testing tool, we determined the efficacy of Vorinostat against aggregates of U87 and KNS42 glioblastoma cells. Both lines demonstrated markedly reduced sensitivity when assaying in 3D culture conditions compared to classical 2D drug screen approaches.<h4>Conclusions</h4>Our comprehensive characterization demonstrates that 3D RCCS culture of high grade brain tumor cells has profound effects on the genetic, epigenetic and metabolic profiles of cultured cells, with these cells residing as an intermediate phenotype between that of 2D cultures and primary tumors. There is a discrepancy between 2D culture and tumor molecular profiles, and RCCS partially re-capitulates tissue specific features, allowing drug testing in a more relevant ex vivo system.Stuart J SmithMartin WilsonJennifer H WardCheryl V RahmanAndrew C PeetDonald C MacarthurFelicity R A J RoseRichard G GrundyRuman RahmanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 12, p e52335 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Stuart J Smith
Martin Wilson
Jennifer H Ward
Cheryl V Rahman
Andrew C Peet
Donald C Macarthur
Felicity R A J Rose
Richard G Grundy
Ruman Rahman
Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.
description <h4>Introduction</h4>Physiologically relevant pre-clinical ex vivo models recapitulating CNS tumor micro-environmental complexity will aid development of biologically-targeted agents. We present comprehensive characterization of tumor aggregates generated using the 3D Rotary Cell Culture System (RCCS).<h4>Methods</h4>CNS cancer cell lines were grown in conventional 2D cultures and the RCCS and comparison with a cohort of 53 pediatric high grade gliomas conducted by genome wide gene expression and microRNA arrays, coupled with immunohistochemistry, ex vivo magnetic resonance spectroscopy and drug sensitivity evaluation using the histone deacetylase inhibitor, Vorinostat.<h4>Results</h4>Macroscopic RCCS aggregates recapitulated the heterogeneous morphology of brain tumors with a distinct proliferating rim, necrotic core and oxygen tension gradient. Gene expression and microRNA analyses revealed significant differences with 3D expression intermediate to 2D cultures and primary brain tumors. Metabolic profiling revealed differential profiles, with an increase in tumor specific metabolites in 3D. To evaluate the potential of the RCCS as a drug testing tool, we determined the efficacy of Vorinostat against aggregates of U87 and KNS42 glioblastoma cells. Both lines demonstrated markedly reduced sensitivity when assaying in 3D culture conditions compared to classical 2D drug screen approaches.<h4>Conclusions</h4>Our comprehensive characterization demonstrates that 3D RCCS culture of high grade brain tumor cells has profound effects on the genetic, epigenetic and metabolic profiles of cultured cells, with these cells residing as an intermediate phenotype between that of 2D cultures and primary tumors. There is a discrepancy between 2D culture and tumor molecular profiles, and RCCS partially re-capitulates tissue specific features, allowing drug testing in a more relevant ex vivo system.
format article
author Stuart J Smith
Martin Wilson
Jennifer H Ward
Cheryl V Rahman
Andrew C Peet
Donald C Macarthur
Felicity R A J Rose
Richard G Grundy
Ruman Rahman
author_facet Stuart J Smith
Martin Wilson
Jennifer H Ward
Cheryl V Rahman
Andrew C Peet
Donald C Macarthur
Felicity R A J Rose
Richard G Grundy
Ruman Rahman
author_sort Stuart J Smith
title Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.
title_short Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.
title_full Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.
title_fullStr Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.
title_full_unstemmed Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.
title_sort recapitulation of tumor heterogeneity and molecular signatures in a 3d brain cancer model with decreased sensitivity to histone deacetylase inhibition.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/0b5326e51f734aaabbbf930afbebf33f
work_keys_str_mv AT stuartjsmith recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT martinwilson recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT jenniferhward recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT cherylvrahman recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT andrewcpeet recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT donaldcmacarthur recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT felicityrajrose recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT richardggrundy recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
AT rumanrahman recapitulationoftumorheterogeneityandmolecularsignaturesina3dbraincancermodelwithdecreasedsensitivitytohistonedeacetylaseinhibition
_version_ 1718422210288287744